Purchase this article with an account.
S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, Y. Ozawa, K. Tsubota, H. Itoh, Y. Oike, S. Ishida; Nonproteolytically Activated Prorenin Promotes Pathologic, but Not Physiologic, Retinal Neovascularization. Invest. Ophthalmol. Vis. Sci. 2007;48(13):4055.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Recently, we revealed that the inhibition of nonproteolytic activation of prorenin led to significant suppression of ocular inflammation in endotoxin-induced uveitis. The purpose of the current study is to investigate whether nonproteolytically activated prorenin plays a role in ischemia-induced retinal neovascularization.
C57BL/6 neonatal mice were reared in 80% concentration of oxygen from postnatal (P) day 7 to P12, followed by room-air breathing to P17 to induce ischemia-initiated retinal neovascularization. Tissue localization of activated prorenin and prorenin receptor was examined by immunohistochemistry. Animals received intraperitoneal injections of handle-region peptide (HRP), a decoy peptide corresponding to the handle region of prorenin, which inhibits prorenin receptor-mediated upregulation of the renin-angiotensin system (RAS). A concanavalin A lectin perfusion-labeling technique was used to evaluate the areas of physiologic and pathologic retinal new vessels and the number of leukocytes adhering to the vasculature. Retinal mRNA expression and protein levels of intercellular adhesion molecule (ICAM) -1, vascular endothelial growth factor (VEGF), VEGF receptor (VEGFR)-1 and VEGFR-2 were examined by RT-PCR and ELISA.
Retinal vessels in ischemic retinopathy eyes were positive for activated prorenin and prorenin receptor. Pathologic, but not physiologic, retinal neovascularization was significantly attenuated in HRP-treated mice compared with vehicle- or control peptide-treated animals. The number of adherent leukocytes was also significantly reduced. Retinal mRNA expression and protein levels of ICAM-1, VEGF, VEGFR-1 and VEGFR-2 in ischemic retinopathy were also significantly suppressed with application of HRP.
The present findings suggest that nonproteolytic activation of prorenin selectively promotes pathologic, but not physiologic, retinal neovascularization through the inflammatory processes related to pathologic neovascularization.
This PDF is available to Subscribers Only